273
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design

, &
Pages 1186-1206 | Received 11 Apr 2011, Accepted 12 May 2011, Published online: 07 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mariana P. Barcellos, Cleydson B. R. Santos, Leonardo B. Federico, Paulo Fernando de Almeida, Carlos H. T. de Paula. da Silva & Carlton A. Taft. (2019) Pharmacophore and structure-based drug design, molecular dynamics and admet/tox studies to design novel potential pad4 inhibitors. Journal of Biomolecular Structure and Dynamics 37:4, pages 966-981.
Read now
Udghosh Singh, Rahul P. Gangwal, Rameshwar Prajapati, Gaurao V. Dhoke & Abhay T. Sangamwar. (2013) 3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors. Molecular Simulation 39:5, pages 385-396.
Read now

Articles from other publishers (1)

Arun JohnVetrivel UmashankarA. SamdaniManoharan SangeethaSubramanian KrishnakumarPerinkulam Ravi Deepa. (2016) In Silico Structure Prediction of Human Fatty Acid Synthase–Dehydratase: A Plausible Model for Understanding Active Site Interactions . Bioinformatics and Biology Insights 10, pages BBI.S38317.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.